Editor of Patient Care Online.
Dupilumab for Severe COPD Shows Efficacy, Tolerability, Patient Satisfaction in New Real-World Study
Dupilumab significantly reduced COPD exacerbations and received high satisfaction ratings from patients with severe disease and Th2 inflammation.
FDA Clears First At-Home Pap Smear Alternative for Cervical Cancer Screening: Daily Dose
Your daily dose of the clinical news you may have missed.
Combined Oral Contraceptive Use May Triple the Risk of Cryptogenic Stroke in Young Women
ESOC 2025: New research reveals that combined oral contraceptive use significantly increases the risk of cryptogenic stroke in young women, urging careful assessment by clinicians.
Mepolizumab Approved as First Biologic to Treat COPD with Eosinophilic Phenotype
Mepolizumab, an IL-5 inhibitor targeting Th2 inflammation characterized by elevate serum eosinophil count, fills a treatment gap for ~70% of adults with uncontrolled COPD.
Colonoscopy Completion Up 69% With Patient Navigation Program After FIT: Daily Dose
The Weekly Dose: How Medicaid Policies Impact Postpartum Depression Care
At ACOG 2025, Elizabeth Mollard, PhD, discussed her research on Medicaid PPD screening and coverage policies on PPD diagnosis.
Novel CBD Cream Shows Promise in Protecting Skin from UV-A Damage in First-Ever In-Human Trial
Results showed that a nanoencapsulated CBD cream reduced UV-A–induced nuclear and mitochondrial DNA damage linked to photoaging in human skin.
Moderna Announces Withdrawal of BLA for Flu/COVID-19 Combination Vaccine
Moderna voluntarily withdrew the BLA after consultation with the FDA and will resubmit once it has additional phase 3 efficacy data for its investigational flu shot.
Atopic Dermatitis Burden in Older Adults May Surge by 2050: Daily Dose
From Screening to Support: How PCPs Can Tackle PPD
ACOG 2025: Joy Baker, MD, urged primary care clinicians to screen early, refer confidently, and help change the statistics on maternal mental health.
Dupilumab Improves Asthma Control, HRQoL Regardless of Comorbid Th2 Inflammatory Disease
Data from the global RAPID registry provide real-world support for dupilumab efficacy in youths and adults with uncontrolled asthma and with or without CRS and/or nasal polyposis.
Johanna Finkle, MD, on Approaching Weight Loss Discussions with Reproductive-Aged Patients
ACOG 2025: Johanna Finkle, MD, shares strategies to start weight conversations with patients and build clinician confidence in counseling and treatment options.
FDA Narrows COVID-19 Vaccine Access to High-Risk Groups, Demands New Trials for Healthy Adults
The FDA's new approach to evaluating and approving COVID-19 vaccines will move the US away from a one-size-fits-all approach and closer to policy in other countries.
Elinzanetant Effective for VMS Across BMI, Smoking Status: Daily Dose
PPD Screening, Medicaid Coverage, and Access to Care: A Q&A with Elizabeth Mollard, PhD
ACOG 2025: Elizabeth Mollard, PhD, discusses her research on how Medicaid policies influence postpartum depression screening rates.
Single Dose of Arexvy RSV Vaccine Shows 3-Year Protection in Older Adults: Daily Dose
Real-World Memory Clinic Data Suggest Lecanemab Use Is Feasible, Practical for Adults with Alzheimer Disease
Adults with early AD who were treated with lecanemab in a specialty memory clinic experienced adverse events comparable to those seen in clinical trials.
“I’m Just Tired”: Listening for the Words Patients Actually Use
ACOG 2025: Joy Baker, MD, discusses the importance of listening closely to how patients describe postpartum distress—and to read between the lines.
FDA Grants Novavax COVID-19 Vaccine Full Approval for High-Risk Groups
Nuvaxovid (NVX-CoV2373) is indicated for those aged ≥65 years and aged 12 to 64 years with at least one condition that puts them at high risk for severe infection.
Laxmi Gannu, MS, Explains a New Study of Clinician's Knowledge of Post Partum Depression
ACOG 2025: The Junonia study was designed to understand gaps in care for women with PPD using surveys of their clinicians and care coordinators.
Nanette Santoro, MD, Highlights Findings on Fezolinetant From Pooled Analysis of Phase 3 Skylight Development Program Trials
The nonhormonal neurokinin-3 receptor antagonist improved menopausal adiposity without appreciable impact on body weight or BMI, Santoro explained at 2025 ACOG meeting.
When We Talk About Perinatal Weight Issues, We Need to Focus on the Whole Person, Johanna Finkle, MD, Reminds Clinicians
ACOG 2025: Pregnant patients may not want to discuss weight gain initially, so focus on overall perinatal health, and use that information to guide more conversation.
Study Shows Sharp Rise in GI Cancers Among Young Adults: Daily Dose
Why Postpartum Depression Is Still Off the Radar in Pregnancy Care
LeThenia Joy Baker, MD, explains why PPD is often overlooked compared to physical pregnancy conditions like gestational diabetes.
Postpartum Inpatient HPV Vaccination Significantly Boosts Uptake at Urban Hospital, Study Finds
An intervention that included educational materials for clinicians on a multidisciplinary prenatal and postpartum care team helped drive acceptance.
Prenatal Substance Use Counseling: Missed Opportunities for Intervention
Pregnant patients' perceptions do not match clinician certainty on abstinence counseling during pregnancy, and clinicians may not be asking patients about their partner's substance use.
Study Reveals Major Gaps in Thyroid Screening During Pregnancy
Researchers report an alarming number of missed opportunities to screen pregnant individuals for thyroid disease, including among women with a history of the condition.
Joy Baker, MD: Understanding Patient Language in PPD Screening
ACOG 2025: Dr Baker shares how language can help create a trusting space for patients to speak openly about postpartum depression.
Postpartum Depression and the Missed Hand-Off to Primary Care
ACOG 2025: Joy Baker, MD, called for stronger cross-specialty collaboration to address maternal mental health after birth.
ACOG 2025: Steven Fleischman, MD, Inaugurated as 76th President, Urges New Fellows to Lead with Purpose
Steven Fleischman, MD, was inaugurated as ACOG’s 76th president, urging new fellows to lead with purpose and recognize their value in women’s health care.
